Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENTION trial: prophylactic noradrenaline during urgent tracheal intubation in critically ill adults
2023-503895-25-00Phase 3Authorised
- Sponsor
- Università degli Studi di Torino
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial of norepinephrine in critical illness (2 arms), sponsored by Università degli Studi di Torino. Primary endpoints: Primary: peri-intubation hypotension (MAP < 60 mmHg) and Primary: cardiac arrest. Planned start Mar 2024; status: authorised.
02
Drugs
norepinephrine
03
Conditions
critical illness
Beyond the preview
Go deeper on 2023-503895-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503895-25-00.